BMJ Open,
Journal Year:
2024,
Volume and Issue:
14(3), P. e083340 - e083340
Published: March 1, 2024
Objectives
To
investigate
the
lived
experiences
of
Long
COVID.
Design
Critical
interpretive
synthesis
qualitative
research.
Data
sources
PubMed
and
Web
Science
databases
were
searched
on
14
September
2023.
Eligibility
criteria
Original
peer-reviewed
studies
describing
COVID
eligible
for
inclusion.
extraction
We
used
established
methods
to
search,
screen
manually
code
included
studies.
interpretation
analyse
data
develop
synthetic
constructs.
Results
68
articles
identified
in
first
phase
sampling,
with
16
879
participants
final
synthesis.
The
analysis
these
was
organised
into
three
thematic
constructions
COVID:
(1)
illness,
(2)
patient
(3)
recovery.
diversely
characterised
across
study
approaches,
designs
findings
but
underpinned
by
shared
diagnostic
logics,
which
shaped
identification
measurement
symptoms.
boundaries
between
different
constitutions
accounts
illness
experience
often
imprecise.
Slippages
definitions
had
implications
relation
diagnosis,
help-seeking
care,
expectations
Conclusions
is
a
site
multiple
diverse
interpretation.
Accounts
emphasise
patienthood
recovery
as
situated
emergent.
ongoing
context-based
negotiation
defining
feature
condition.
Approaches
researching,
diagnosing
developing
health
interventions
must
be
adaptive
varieties
experience.
EClinicalMedicine,
Journal Year:
2024,
Volume and Issue:
70, P. 102517 - 102517
Published: March 14, 2024
Repurposed
drugs
with
host-directed
antiviral
and
immunomodulatory
properties
have
shown
promise
in
the
treatment
of
COVID-19,
but
few
trials
studied
combinations
these
agents.
The
aim
this
trial
was
to
assess
effectiveness
affordable,
widely
available,
repurposed
used
combination
for
which
may
be
particularly
relevant
low-resource
countries.
BMC Public Health,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: March 13, 2024
Abstract
Background
Around
one
in
ten
people
who
contract
Covid-19
report
ongoing
symptoms
or
‘Long
Covid’.
Without
any
known
interventions
to
cure
the
condition,
forms
of
self-management
are
routinely
prescribed
by
healthcare
professionals
and
described
with
condition.
However,
there
is
limited
research
exploring
what
strategies
used
navigate
everyday
life
Long
Covid,
experiences
that
initiate
development
these
strategies.
Our
study
aimed
explore
range
influence
self-generated
Covid
within
context
their
own
Methods
Forming
part
Personalised
Self-managemenT
support
co-design
EvaluatioN
(LISTEN)
project,
we
conducted
a
qualitative
using
narrative
interviews
adults
were
not
hospitalised
Covid-19.
Participants
aged
over
18
years,
self-identified
recruited
from
England
Wales.
Data
analysed
patient
contributors
reflexive
thematic
analysis.
Results
Eighteen
participants
(mean
age
=
44
SD
13
years)
took
held
between
December
2021
February
2022.
Themes
constructed
which
depicted
1)
landscape
behind
experience
2)
participants’
Covid.
The
comprised
combination
physical,
emotional,
social
factors,
forming
three
sub-themes:
centrality
physical
symptoms,
navigating
‘experts’
‘true
colour’
personal
communities,
rollercoaster
psychological
ambiguity
).
third
theme,
manage
was
unique
presentations
solutions
life.
This
five
seeking
reassurance
knowledge,
developing
greater
self-awareness
through
monitoring,
trial
error
‘safe’
ideas,
building
pleasure
comfort,
prioritising
‘me’
.
Conclusions
Among
this
sample
highlighted
unpredictable
nature
condition
but
also
use
creative
wide
ranging
results
offer
supporting
them,
an
overview
collective
evidence
relating
individuals'
can
enable
ways
live
‘better’
regain
some
sense
identity
whilst
facing
impact
debilitating,
episodic
Trial
registration
LISTEN
ISRCTN36407216.
International Journal of Environmental Research and Public Health,
Journal Year:
2023,
Volume and Issue:
20(4), P. 3100 - 3100
Published: Feb. 10, 2023
The
current
pilot
study
was
set
to
evaluate
the
feasibility
and
potential
benefit
of
a
personalized
computerized
cognitive
training
(CCT)
intervention
improve
function
among
people
living
with
post-acute
sequelae
COVID-19
(PASC).
Seventy
three
adults
who
self-reported
dysfunction
more
than
3
months
after
diagnosis
took
part
in
an
8-week
study.
Participants'
general
assessed
before
they
completed
as
many
daily
sessions
wished
during
period,
using
CCT
application
at
home.
At
end
this
participants
repeated
assessment.
differences
between
scores
8
weeks
baseline
five
domains
(attention,
memory,
coordination,
perception,
reasoning),
complemented
analyses
changes
based
on
participants'
age,
time,
health
level
time
since
initial
infection.
Participants
had
significant
negative
levels
baseline.
Most
obtained
higher
each
compared
magnitude
score
increase
high
across
domains.
It
is
concluded
that
self-administered
gamified
tasks
could
be
effective
way
ameliorate
persons
PASC.
ClinicalTrials.gov
identifier
NCT05571852.
AJP Gastrointestinal and Liver Physiology,
Journal Year:
2023,
Volume and Issue:
324(4), P. G322 - G328
Published: March 7, 2023
The
COVID-19
pandemic
has
resulted
in
the
infection
of
hundreds
millions
individuals
over
past
3
years,
coupled
with
deaths.
Along
these
more
acute
impacts
infection,
a
large
subset
patients
developed
symptoms
that
collectively
comprise
"postacute
sequelae
COVID-19"
(PASC,
also
known
as
long
COVID),
which
can
persist
for
months
and
maybe
even
years.
In
this
review,
we
outline
current
knowledge
on
role
impaired
microbiota-gut-brain
(MGB)
axis
signaling
development
PASC
potential
mechanisms
involved,
may
lead
to
better
understanding
disease
progression
treatment
options
future.
Frontiers in Psychiatry,
Journal Year:
2023,
Volume and Issue:
14
Published: March 24, 2023
SARS-CoV-2
(COVID-19)
infection
can
result
in
long-term
health
consequences
i.e.,
long
COVID.
The
clinical
manifestations
of
COVID
include
depression,
anxiety,
brain
fog
with
cognitive
dysfunction,
memory
issues,
and
fatigue.
These
delayed
effects
COVID-19
occur
up
to
30%
people
who
have
had
an
acute
case
COVID-19.
In
this
report,
a
72-year-old,
fully
vaccinated
patient
without
pre-existing
somatic
or
mental
illnesses,
other
relevant
risk
factors
was
diagnosed
Nine
months
following
infection,
the
patient's
depressive
symptoms
improved,
but
concentration
difficulties
persisted,
remains
unable
resume
work.
are
possibly
linked
micro-hemorrhages
detected
during
examinations
infection.
Patient
treatment
complex,
positive
results
were
attained
via
antidepressants
non-drug
therapies
e.g.,
art,
music,
drama,
dance
movement
therapy,
physiotherapy,
occupational
psychotherapy.
Frontiers in Neurology,
Journal Year:
2023,
Volume and Issue:
14
Published: Aug. 24, 2023
Introduction
As
the
repercussions
from
COVID-19
pandemic
continue
to
unfold,
an
ever-expanding
body
of
evidence
suggests
that
infection
also
elicits
pathophysiological
manifestations
within
central
nervous
system
(CNS),
known
as
neurological
symptoms
post-acute
sequelae
COVID
(NeuroPASC).
Although
impairments
and
associated
with
NeuroPASC
have
been
well
described
in
literature,
its
etiology
remains
be
fully
characterized.
Objectives
This
mini-review
explores
current
literature
elucidates
various
mechanisms
underlining
NeuroPASC,
players,
regulators,
leading
persistent
neuroinflammation
affected
individuals.
Specifically,
we
provide
some
insights
into
roles
played
by
microglial
astroglial
cell
reactivity
how
these
subsets
potentially
contribute
impairment
response
direct
or
indirect
CNS
injury.
Discussion
A
better
understanding
biomarkers
this
maladaptive
neuroimmune
will
thus
diagnostic
strategies
for
reveal
new
potential
therapeutic
intervention.
Altogether,
elucidation
pathogenesis
improve
patient
outcomes
mitigate
socioeconomic
burden
syndrome.
Gut Microbes,
Journal Year:
2025,
Volume and Issue:
17(1)
Published: Jan. 24, 2025
Post-acute
coronavirus
disease
2019
syndrome
(PACS),
following
severe
acute
respiratory
2
(SARS-CoV-2)
infection
or
(COVID-19),
is
typically
characterized
by
long-term
debilitating
symptoms
affecting
multiple
organs
and
systems.
Unfortunately,
there
currently
a
lack
of
effective
treatment
strategies.
Altered
gut
microbiome
has
been
proposed
as
one
the
plausible
mechanisms
involved
in
pathogenesis
PACS;
extensive
studies
have
emerged
to
bridge
gap
between
persistent
dysbiosis
microbiome.
Recent
clinical
trials
indicated
that
modulation
using
probiotics,
prebiotics,
fecal
microbiota
transplantation
(FMT)
led
improvements
related
PACS,
including
fatigue,
memory
loss,
difficulty
concentration,
gastrointestinal
upset,
disturbances
sleep
mood.
In
this
review,
we
highlight
latest
evidence
on
key
microbial
alterations
observed
well
use
microbiome-based
therapeutics
managing
PACS
symptoms.
These
novel
findings
altogether
shed
light
other
chronic
conditions.